Document is current
Any future updates will be listed below
-
Authors
Holden, Andrew https://orcid.org/0000-0002-8170-4960
Haruguchi, Hiroaki https://orcid.org/0000-0001-5713-987X
Suemitsu, Kotaro https://orcid.org/0000-0002-4251-5315
Isogai, Naoko https://orcid.org/0000-0003-3332-2527
Hull, Jeffrey https://orcid.org/0000-0003-4094-5810
Wiechmann, Bret N. https://orcid.org/0000-0002-7022-497X
Wang, Hong https://orcid.org/0000-0001-5424-3946
Seamans, Jennifer
Lookstein, Robert https://orcid.org/0009-0001-4109-0634
,
Kirksey, Levester
Parod, Federico
Hardy, David
Lyden, Sean
Misra, Sanjay
Bjarnason, Haraldur
Stockland, Andrew
Neider, Newton
Bendel, Emily
Reisenauer, Christopher
Neisen, Melissa
Knavel, Erica
Santos, Angelo
Laurich, Chad
Kelly, Patrick
Abul-Khoudoud, Omran
Hou, Alexander
Lewis, Paul
Friedman, Adie
Dudkiewicz, Michael
Dreifuss, Ronald
Rundback, John
Herman, Kevin
Khudari, Husameddin El
Aal, Ahmed Kamel Abdel
Ertel, Nathan
Oser, Rachel
Gunn, Andrew
Sharafuddin, Mel
Laroia, Sandeep
Sun, Shiliang
O’Shea, Brendan
Miller, Brian
Kresowik, Timothy
Sharp, William
Wang, Shengfu
Madassery, Sreekumar
Dexter, David
Steerman, Samuel
Rathore, Animesh
DeMasi, Richard
Stokes, Gordon
McEnroe, Scott
Joels, Charles
Fugate, Mark
Greer, Michael
Sprouse, Larry Richard
Horn, Jeff
Hussain, Syed
Karagiorgos, Nikolaos
Ash, Jennifer
Bagla, Sandeep
Piechowiak, Rachel
London, Mark
Ross, John
Ewart, Jackson
Hakmei, Jalal
Sheta, Mohamed
Hoggard, Jeffrey
Gupta, Karn
Patel, Sejan
Mann, Wesley
Atray, Naveen
Kashyap, Rohit
Ramani, Karthik
Cooper, Randy
Pervez, Aslam
Waheed, Umar
Mawla, Neghae
Beathard, Steven
Kafie, Fernando
McDaniel, Huey
Matsuoka, Yuki
Ota, Naomi
Oka, Kanako
Kawanishi, Saho
Ogino, Hidemitsu
Miyake, Katsunori
Shimoyama, Rai
Kawachi, Jun
Murata, Takaaki
Kum, Nao
Igarashi, Yuto
Sunou, Yuma
Hidaka, Sumi
Ishioka, Kunihiro
Fujihara, Masahiko
Yokoi, Yoshiaki
Higashimori, Akihiro
Morioka, Nobuyuki
Shiotani, Shinji
Fukuda, Keisuke
Tsukizawa, Tomofumi
Kuwabara, Kensuke
Matsuo, Yoshiki
Tanabe, Yuma
Murakami, Masaaki
Mori, Noriko
Mori, Kiyoshi
Tanaka, Satoshi
Matsuo, Ken
Okawa, Takao
Okamura, Shunsuke
Soma, Yu
Yamamoto, Yoshihiro
Kimura, Shota
Ito, Yuki
Sugawara, Akira
Ito, Kenta
Yamada, Ryo
Matsuo, Yoko
Hagiwara, Kakuya
Iwadoh, Kazuhiro
Nakajima, Ichiro
Fuchinoue, Shohei
Hirotani, Sachiko
Kai, Kotaro
Ogawa, Yuichi
Miki, Katsuyuki
Hachisuka, Takeshi
Morita, Sayaka
Kondo, Akira
Ogawa, Tomonari
Hasegawa, Hajime
Hida, Toru
Shimizu, Taisuke
Abe, Nozomi
Sano, Tatsuro
Yasuda, Kunihiko
Kiba, Tota
Okada, Yoshimi
Ogawa, Koki
Hara, Hiroaki
Hirose, Kento
Kawai, Yuichiro
Buckley, Brendan
Connor, Brigid
Merrilees, Stephen
Semple, David
Hill, Andrew
Kesara, Janaka
Wickremesekera,
Evans, Richard
Taumoepeau, Lupe
Narayanan, Anantha
Baimatova, Irina
-
Funding
Funding for this research was provided by:
Medtronic
- License Information
-
More Information
Article History
Received: 8 May 2026
Accepted: 23 July 2026
First Online: 19 August 2026
Declarations
Ethics approval and consent to participate: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.Informed consent was obtained from all individual participants included in the study.
Consent for publication: Consent for publication was obtained for every individual person’s data included in the study.
Competing interests: Andrew Holden is a scientific advisory board member for Boston Scientific, Gore, Medtronic, and Philips and a clinical trial investigator for Medtronic and Surmodics. Hiroaki Haruguchi receives consulting fees from Medtronic. Kotaro Suemitsu receives lecture fees from Medtronic. Naoko Isogai reports no conflicts of interest. Jeffrey Hull reports no conflicts of interest. Bret Wiechmann is a consultant for BD, MicroMedical Solutions, Cordis, Abbott Vascular, and Veryan Medical. Hong Wang and Jennifer Seamans are full-time employees of Medtronic and own Medtronic stock and stock options. Robert Lookstein’s institution has received grants from Black Swan, Inari, Terumo, and Vesper Medical. He is a consultant for Abbott Vascular, Boston Scientific, Imperative Vascular, Medtronic, and Penumbra; has received payment for expert testimony from Hof and Reid; participates as an advisory board member for Abbott Vascular, Boston Scientific, and Medtronic; and holds stock or stock options in Imperative Vascular, Innova Vascular, Sonovascular, and Thrombolex. He is the immediate past president of the PERT Consortium, a member of the Board of Directors of the CLI Global Society, and President of the Society of Interventional Radiology.
